secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001193125-22-289077
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics director Neil Exter retires; board size reduced to eight
----------------------------------------------------------------------------

- Neil Exter retired from the Board and Compensation Committee effective November 16, 2022.
- Retirement not due to any disagreement with the company on operations, policies, or practices.
- Board size reduced from nine to eight members, effective November 17, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522289077/0001193125-22-289077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522289077/d421789d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-289077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer